<DOC>
	<DOCNO>NCT01925586</DOCNO>
	<brief_summary>This study design look whether feasible observe woman atypical ductal hyperplasia ( ADH ) breast , whether surgical excision necessary .</brief_summary>
	<brief_title>Atypical Lesions Breast : Close Observation Versus Excision ( ALCOVE )</brief_title>
	<detailed_description>We hypothesize surgical excision may yield improvement survival hormonal therapy and/or close observation alone patient present ADH core needle biopsy breast . An alternate ( non-inferior ) strategy management may possible , may associate improved quality life few complication , low overall cost . Although several researcher suggest clinical trial investigate idea would first time do , could therefore practice changing .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<criteria>Inclusion Criteria A patient/subject eligible enrollment follow inclusion criterion meet : 1 . Pre postmenopausal woman â‰¥ 40 year age newly diagnose ADH , histologically confirm breast core biopsy . 2 . Ability understand willingness sign write informed consent document . 3 . Willing schedule definitive resection ADH randomize surgical excision arm observe randomized observation arm . 4 . Original breast core biopsy specimen available pathologic review stain Yale School Medicine Department Pathology . Exclusion Criteria A patient/subject eligible study follow exclusion criterion meet : 1 . Patients current breast cancer diagnosis personal history cancer 2 . Patients personal history identifiable genetic mutation ( BRCA ) breast cancer , untested first degree relative mutation carrier 3 . Patients previously currently take tamoxifen exemestane chemotherapy biologic therapy ( e.g . trastuzumab ) 4 . Patients history radiation therapy chest wall 5 . Pregnant and/or lactate woman within past 6 month .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>